Potential cardiovascular adverse events when phenylephrine is combined with paracetamol: simulation and narrative review

BACKGROUND: Increased bioavailability of phenylephrine is reported when combined with paracetamol in over-the-counter formulations for the symptomatic treatment of the common cold and influenza. Such formulations could increase phenylephrine-related cardiovascular adverse events particularly in susc...

Descripción completa

Detalles Bibliográficos
Autores principales: Atkinson, Hartley C., Potts, Amanda L., Anderson, Brian J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Pharmacodynamics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500855/
https://www.ncbi.nlm.nih.gov/pubmed/26022219
http://dx.doi.org/10.1007/s00228-015-1876-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4500855/
https://www.ncbi.nlm.nih.gov/pubmed/26022219
http://dx.doi.org/10.1007/s00228-015-1876-1

Ejemplares similares